Clinical significance of heat shock proteins in gastric cancer following hyperthermia stress: Indications for hyperthermic intraperitoneal chemoperfusion therapy

Tu,Yinuo; Tian,Yunhong; Wu,Yinbing; Cui,Shuzhong

doi:10.3892/ol.2018.8508

Clinical significance of heat shock proteins in gastric cancer following hyperthermia stress: Indications for hyperthermic intraperitoneal chemoperfusion therapy

Authors:
- Yinuo Tu
- Yunhong Tian
- Yinbing Wu
- Shuzhong Cui
View Affiliations

Affiliations: Intracelom Hyperthermic Perfusion Therapy Center, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China, Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong 510095, P.R. China
Published online on: April 16, 2018 https://doi.org/10.3892/ol.2018.8508
Pages: 9385-9391

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Heat shock proteins (HSPs) are important factors in the response of cancer cells to thermo‑ and chemotherapy. Transient hyperthermic intraperitoneal chemoperfusion (HIPEC) therapy results in the upregulation of HSP expression, which may compromise the efficacy of additional anticancer treatments. The aim of the present study was to monitor the kinetics of HSP expression in tumor cells and patients with gastric cancer following HIPEC. Thus, in vitro and in vivo experiments were conducted to investigate the expression of two HSP family members, HSP70 and HSP90. Cells from two gastric tumor strains were subjected to HIPEC‑mimicking treatment, and HSPs expression was analyzed at specific time points up to 48 h. Serum HSP concentrations were analyzed in patients with gastric cancer who had previously received cytoreductive surgery plus HIPEC treatment. The in vitro experiments indicated a significant elevation of HSP90 expression in gastric adenocarcinoma cells following hyperthermic treatment. However, HSP70 expression increased from 4 h up to 20 h post‑exposure and decreased to normal levels 36 h post‑exposure. Analysis of HSPs in serum samples collected from 22 patients with gastric cancer confirmed that serum HSP90 and HSP70 levels increased following HIPEC therapy, peaking at 18 h and returning to normal 24 h post‑exposure. It is therefore advisable to apply the second round of HIPEC or chemotherapy at least 24 h following the first treatment to minimize any potential thermoresistance and chemoresistance of tumor cells.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
2	Bieri U, Moch H, Dehler S, Korol D and Rohrmann S: Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: A longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich. Virchows Arch. 466:637–643. 2015. View Article : Google Scholar : PubMed/NCBI
3	Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of disease study 2010. Lancet. 380:2095–2128. 2012. View Article : Google Scholar : PubMed/NCBI
4	Yonemura Y, Endou Y, Sasaki T, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M and Li Y: Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur J Surg Oncol. 36:1131–1138. 2010. View Article : Google Scholar : PubMed/NCBI
5	Coccolini F, Gheza F, Lotti M, Virzì S, Iusco D, Ghermandi C, Melotti R, Baiocchi G, Giulini SM, Ansaloni L and Catena F: Peritoneal carcinomatosis. World J Gastroenterol. 19:6979–6994. 2013. View Article : Google Scholar : PubMed/NCBI
6	Yonemura Y, Kawamura T, Bandou E, Tsukiyama G, Endou Y and Miura M: The natural history of free cancer cells in the peritoneal cavity. Recent Results Cancer Res. 169:11–23. 2007.PubMed/NCBI
7	Klaver YL, Lemmens VE, Creemers GJ, Rutten HJ, Nienhuijs SW and de Hingh IH: Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol. 22:2250–2256. 2011. View Article : Google Scholar : PubMed/NCBI
8	Sugarbaker PH and Ryan DP: Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: Standard of care or an experimental approach? Lancet Oncol. 13:e362–e369. 2012. View Article : Google Scholar : PubMed/NCBI
9	Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, Votanopoulos K, Stewart JH, Shen P and Levine EA: Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 109:740–745. 2014. View Article : Google Scholar : PubMed/NCBI
10	McConnell YJ, Mack LA, Gui X, Carr NJ, Sideris L, Temple WJ, Dubé P, Chandrakumaran K, Moran BJ and Cecil TD: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: An emerging treatment option for advanced goblet cell tumors of the appendix. Ann Surg Oncol. 21:1975–1982. 2014. View Article : Google Scholar : PubMed/NCBI
11	Graziosi L, Cantarella F, Mingrone E, Gunnellini M, Cavazzoni E, Liberati M and Donini A: Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer. Ann Ital Chir. 84:551–556. 2013.PubMed/NCBI
12	Mallory M, Gogineni E, Jones GC, Greer L and Simone CB II: Therapeutic hyperthermia: The old, the new, and the upcoming. Crit Rev Oncol Hematol. 97:56–64. 2016. View Article : Google Scholar : PubMed/NCBI
13	Kepenekian V, Aloy MT, Magné N, Passot G, Armandy E, Decullier E, Sayag-Beaujard A, Gilly FN, Glehen O and Rodriguez-Lafrasse C: Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis. Cell Stress Chaperones. 18:623–630. 2013. View Article : Google Scholar : PubMed/NCBI
14	Lianos GD, Alexiou GA, Mangano A, Mangano A, Rausei S, Boni L, Dionigi G and Roukos DH: The role of heat shock proteins in cancer. Cancer Lett. 360:114–118. 2015. View Article : Google Scholar : PubMed/NCBI
15	Ischia J and So AI: The role of heat shock proteins in bladder cancer. Nat Rev Urol. 10:386–395. 2013. View Article : Google Scholar : PubMed/NCBI
16	Zorzi E and Bonvini P: Inducible hsp70 in the regulation of cancer cell survival: Analysis of chaperone induction, expression and activity. Cancers (Basel). 3:3921–3956. 2011. View Article : Google Scholar : PubMed/NCBI
17	Wang X, Chen M, Zhou J and Zhang X: HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review). Int J Oncol. 45:18–30. 2014. View Article : Google Scholar : PubMed/NCBI
18	Schilling D, Bayer C, Li W, Molls M, Vaupel P and Multhoff G: Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1α. PLoS One. 7:e311102012. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Sugarbaker PH: Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Tumori. 87:S3–S5. 2001. View Article : Google Scholar : PubMed/NCBI
21	Fang C, Hua J, Li J, Zhen J, Wang F, Zhao Q, Shuang J and Du J: Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymphadenectomy for advanced gastric cancer. Am J Surg. 208:391–396. 2014. View Article : Google Scholar : PubMed/NCBI
22	Kow AW, Kwon CH, Song S, Shin M, Kim JM and Joh JW: Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: Review of 1222 cases of hepatectomy in a tertiary institution. Ann Surg Oncol. 19:2246–2255. 2012. View Article : Google Scholar : PubMed/NCBI
23	Rodriguez EF, Monaco SE, Khalbuss W, Austin RM and Pantanowitz L: Abdominopelvic washings: A comprehensive review. Cytojournal. 10:72013. View Article : Google Scholar : PubMed/NCBI
24	Königsrainer I, Horvath P, Struller F, Forkl V, Königsrainer A and Beckert S: Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies. Langenbecks Arch Surg. 398:745–749. 2013. View Article : Google Scholar : PubMed/NCBI
25	Cashin PH, Graf W, Nygren P and Mahteme H: Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Prognosis and treatment of recurrences in a cohort study. Eur J Surg Oncol. 38:509–515. 2012. View Article : Google Scholar : PubMed/NCBI
26	Sevin M, Girodon F, Garrido C and de Thonel A: HSP90 and HSP70: Implication in inflammation processes and therapeutic approaches for myeloproliferative neoplasms. Mediators Inflamm. 2015:9702422015. View Article : Google Scholar : PubMed/NCBI
27	Jego G, Hazoumé A, Seigneuric R and Garrido C: Targeting heat shock proteins in cancer. Cancer Lett. 332:275–285. 2013. View Article : Google Scholar : PubMed/NCBI
28	Sherman MY and Gabai VL: Hsp70 in cancer: Back to the future. Oncogene. 34:4153–4161. 2015. View Article : Google Scholar : PubMed/NCBI
29	Cui XB, Yu ZY, Wang W, Zheng YQ, Liu W and Li LX: Co-inhibition of HSP70/HSP90 synergistically sensitizes nasopharyngeal carcinoma cells to thermotherapy. Integr Cancer Ther. 11:61–67. 2012. View Article : Google Scholar : PubMed/NCBI
30	Miyagawa T, Saito H, Minamiya Y, Mitobe K, Takashima S, Takahashi N, Ito A, Imai K, Motoyama S and Ogawa J: Inhibition of Hsp90 and 70 sensitizes melanoma cells to hyperthermia using ferromagnetic particles with a low Curie temperature. Int J Clin Oncol. 19:722–730. 2014. View Article : Google Scholar : PubMed/NCBI
31	Pelz JO, Vetterlein M, Grimmig T, Kerscher AG, Moll E, Lazariotou M, Matthes N, Faber M, Germer CT, Waaga-Gasser AM and Gasser M: Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: Role of heat shock proteins and dissecting effects of hyperthermia. Ann Surg Oncol. 20:1105–1113. 2013. View Article : Google Scholar : PubMed/NCBI